Transaction · 0000914190-26-000083

Crouse Steven C.

Crouse Steven C., PRES, SB, reported a transaction classified as exercise at BIO-TECHNE Corp involving 794.000000 shares. Reported holdings after the transaction were 6688.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MPRES, SB
TECHBIO-TECHNE Corp
Trade date
May 01, 2026
Filing date
May 05, 2026
View on SEC Insider profile
Estimated value—Shares × reported price
Shares traded794Price unknown
Holdings after6.68kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

TECH price since this filing

Daily closing prices, with the filing date and available return windows
TECH · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -2.8%1w ago1d ago
Returns since7d30d -7.7%90d +31.1%180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0000914190-26-000083
Common Stock
Transaction date
May 01, 2026
Filed May 05, 2026, 08:12 PM · 4d delay
Shares
794 sh
Price unknown
Estimated value
—
Computed from shares × price
Holdings after
6,688 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership
Filing-only score

-2 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • missing_price-8 points

    price_cents is null

    Missing price reduces confidence in value-based signals.
Missing facts
  • price_cents
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President - Diag & Spatial Bi

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

  2. F2

    794 restricted stock units vest on 5/1/2026 and 5/1/2027.

  3. F3

    600 restricted stock units vest on each of 6/2/2026, 6/2/2027 and 6/2/2028.

  4. F4

    1,379 restricted stock units vest on 8/15/2026.

  5. F5

    1,868 restricted stock units vest on 8/15/2026 and 1,869 restricted stock units vest on 8/15/2027.

  6. F6

    2,176 restricted stock units vest on each of 8/15/2026 and 8/15/2028; and 2,177 restricted stock units vest on 8/15/2027.

  7. F7

    100% vested.

  8. F8

    Options to purchase 6,140 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026.

  9. F9

    Options to purchase 3,162 shares vest on each of 8/15/2024, 8/15/2026 and 8/15/2027; and options to purchase 3,163 shares vest on 8/15/2025.

  10. F10

    Options to purchase 1,832 shares vest on each of 5/1/2025, 5/1/2026 and 5/1/2028; and options to purchase 1,831 shares vest on 5/1/2027.

  11. F11

    Options to purchase 4,283 shares vest on each of 8/15/2025, 8/15/2027 and 8/15/2028; and options to purchase 4,284 shares vest on 8/15/2026.

  12. F12

    Options to purchase 1,359 shares vest on each of 6/2/2026 and 6/2/2028; and options to purchase 1,358 shares vest on each of 6/2/2027 and 6/2/2029.

  13. F13

    Options to purchase 4,788 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2029; and options to purchase 4,787 shares vest on 8/15/2028.

  14. F14

    Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

  15. F15

    245 restricted stock units vest on 3/2/2027, 3/2/2028 and 3/2/2029.

  16. F16

    Options to purchase 478 shares vest on each of 3/2/2027, 3/2/2028 and 3/2/2030; and options to purchase 477 shares vest on 3/2/2029.

Original filing · 0000914190-26-000083
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

TECH